cancer

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting…

1 month ago

Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME

 Two oral presentations and multiple posters on clinical andpreclinical-stage candidates to be presented at SITC, demonstratingthe strength of Immatics’ TCR-T…

1 month ago

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting…

1 month ago

Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

New data showed a correlation between the levels of neural cell adhesion molecule (NCAM or CD56) expression and response and…

1 month ago

Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

November 08, 2024 10:00 ET | Source: Medicenna Therapeutics Corp.    MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” BiSKIT…

1 month ago

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting…

2 months ago

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting…

2 months ago

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting…

2 months ago

Sonrai Accelerates Cancer Therapeutics Research with Advanced Analytics

BELFAST, Northern Ireland, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonrai Analytics (Sonrai), an AI precision medicine company providing advanced analytics…

2 months ago

National Comprehensive Cancer Network Joins with Vietnam National Cancer Hospital to Enhance Cancer Treatment

International collaboration meets in Vietnam to facilitate treatment recommendation guidelines that help people with cancer to live better lives. HANOI,…

2 months ago